Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024. In the quarter to June 2026, revenue grew 49.5%, EPS grew 8.82%, free cash flow grew 211.8% and total debt fell 2.15%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

164.84 0.76 −0.46%
Market cap
$9.8B
P/E
0.0×
Fwd P/E
−139×
Dividend yield
—
F-score
3/9
Altman Z
15.20
Beneish M
−2.96
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
13.41 11.33 12.73 9.96
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
554.57 (498.69) 943.64 (463.91)
P/B ratio
12.04 9.31 9.84 6.08
Price to Tangible BV
16.82 13.26 14.43 10.67
EV/Sales
13.51 11.46 12.86 10.12
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(8,716.70) (718.34) (441.27) (225.08)
EV/FCF
(678.98) (180.03) (167.07) (107.54)
Quick Ratio
4.15 4.43 3.82 4.26
Current Ratio
5.04 5.43 4.69 5.20
Net Debt/EBITDA
30.16 29.18 1.66 30.75
Debt/Assets
7.32% 7.58% 7.62% 6.85%
Debt/Equity
0.10 0.10 0.10 0.09
Asset Turnover
0.64 0.59 0.54 0.49
Operating CF/Net income
(0.81) 0.63 (0.05) 0.62
Capex/Depreciation
(0.27) (0.31) (0.23) (0.17)
Interest Coverage
(11.83) (17.65) (122.05) (13.93)
Research and Development Expense of Revenue
28.45% 29.32% 30.50% 28.51%
Selling, General and Administrative Expense of Revenue
62.53% 61.73% 66.17% 62.15%
Intangible Assets out of Total Assets
0.21 0.22 0.23 0.33
Share Based Compensation of Revenue
15.55% 12.71% 12.09% 11.17%
Graham Net Nets
0.03 0.04 0.04 0.05
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(2.33%) (3.05%) (2.89%) (1.89%)
Free Cash Flow Yield
(0.15%) (0.56%) (0.60%) (0.94%)
Revenue per Share
3.16 2.60 2.50 2.33
Operating CF per Share
0.25 (0.22) 0.12 (0.18)
Capex per Share
(0.05) (0.07) (0.05) (0.03)
Free Cash Flow per Share
0.21 (0.28) 0.07 (0.20)
Cash per Share
4.87 4.77 4.87 4.77
Shareholders Equity per Share
11.60 11.56 11.47 13.41
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
11.60 11.56 11.47 13.41
Free Cash Flow
12.09 (16.48) 3.93 (11.72)
Working Capital
413.45 396.34 373.71 367.25
Capital Expenditures
(2.74) (3.96) (2.91) (1.63)
Net Current Asset Value
277.74 263.36 237.65 224.93
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.03 0.02 0.01
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
110.94 95.61 84.68 77.55
Average Payables
16.41 17.49 18.83 15.49
Average Inventory
61.96 60.92 60.62 61.88
Average Assets
953.74 929.75 934.12 962.96
Average Common Equity
723.80 717.44 711.54 719.03

Fold the line items

Columns are period end dates